News | Radiation Dose Management | April 17, 2017

University of California Study Searches for Consistent CT Dose Best Practices

Study across five medical centers stresses importance of sharing dose information across institutions to develop standards

University of California Study Searches for Consistent CT Dose Best Practices

April 17, 2017 — A new study led by UC San Francisco has found that radiation doses can be safely and effectively reduced – and more consistently administered – for common computed tomography (CT) scans by assessing and comparing doses across hospitals, and then sharing best practices for how much radiation to use.

While there has been a steady rise in the use of CT in the United States over the last decade, doses of radiation vary substantially between hospitals, with few concrete standards on best dose levels. As a result, medical experts have difficulty determining the “right” dose of radiation that balances diagnostic accuracy, while minimizing the radiation exposure that increases cancer risk for patients. Without a consistent standard, each institution generally makes independent decisions about what dose to use.   

A new project at the five academic medical centers of the University of California introduced a feedback system for radiologists on their doses and sought to study its effectiveness in reducing excess radiation exposure. The program consisted of auditing radiology professionals at each medical center and providing feedback on how these doses compared to those used at the other medical centers, while systematically sharing best practices. Included in the project were section chiefs of radiology, medical physicists and radiology technicians.

The project resulted in substantially lower radiation doses for chest and abdominal scans, as well as more consistent radiation doses for head scans, according to the study which appears April 10 in JAMA Internal Medicine.

“We estimate that if the improvements we saw were applied to all abdominal CT scans performed in the U.S., this would result in the reduction of approximately 12,000 cancers annually,” said senior author Rebecca Smith-Bindman, M.D., a professor in the UCSF departments of radiology, and of epidemiology and biostatistics, and the Philip R. Lee Institute of Health Policy Studies. Smith-Bindman also directs the Radiology Outcomes Research Laboratory.

“Reducing unnecessary and inconsistent radiation doses is an extremely important process for improving patient safety,” she said. “We found that providing detailed and comparative feedback, and sharing best practices on how each institution was able to optimize their dose, leads to lower and more consistent CT doses. In short, it makes no sense for each institution to have to reinvent the wheel regarding how to optimize doses – this project focuses on helping the leaders at each institution learn from each other.”

 

Related Cardiac CT Dose Articles and Videos:

• Radiation Dose Management Trends and Best Practices

• VIDEO: Radiation Dose Monitoring in Medical Imaging

• National Dose Levels Established for 10 Common Adult CT Examinations

• CT Cancer Risk Poorly Understood by Many Healthcare Providers
 

For more information: www.jamanetwork.com/journals/jamainternalmedicine


Related Content

News | Cardiovascular Clinical Studies

Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...

Home November 18, 2024
Home
News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
News | Cardiovascular Clinical Studies

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
News | Cardiovascular Clinical Studies

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

Home July 09, 2024
Home
News | Cardiovascular Clinical Studies

June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...

Home June 26, 2024
Home
News | Cardiovascular Clinical Studies

June 21, 2024 — Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of ...

Home June 21, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — Microbot Medical Inc. announced its agreement with Brigham and Women’s Hospital (BWH), a leading ...

Home June 20, 2024
Home
Subscribe Now